The blockade of angiotensin II synthesis attenuates hepatic fibrosis in different
experimental models of chronic liver injury. We aimed to determine the safety and efficacy of
moexipril, an angiotensin-converting enzyme (ACE) inhibitor, on liver biochemistries, Mayo
risk score, and health-related quality of life in patients with primary biliary cirrhosis
(PBC) who have had a suboptimal response to ursodeoxycholic acid (UDCA).
The blockade of angiotensin II synthesis attenuates hepatic fibrosis in different
experimental models of chronic liver injury. We aimed to determine the safety and efficacy of
moexipril, an angiotensin-converting enzyme (ACE) inhibitor, on liver biochemistries, Mayo
risk score, and health-related quality of life in patients with primary biliary cirrhosis
(PBC) who have had a suboptimal response to ursodeoxycholic acid (UDCA).
Moexipril HCl/Hydrochlorothiazide 15/25 mg Tablets Under Non-Fasting Conditions
Completed
Teva Pharmaceuticals USA
Phase 1
2003-10-01
The objective of this study is to compare the relative bioavailability of moexipril HCl/
hydrochlorothiazide 15/25 mg tablets (manufactured and distributed by TEVA Pharmaceuticals
USA) with that of UNIRETIC® 15/25 mg tablets (Schwartz Pharma) in healthy, adult, non-smoking
subjects under non-fasting conditions.
Moexipril HCL/Hydrochlorothiazide 15/25 mg Tablets Under Fasting Conditions
Completed
Teva Pharmaceuticals USA
Phase 1
2003-10-01
The objective of this study is to compare the relative bioavailability of Moexipril
HCl/hydrochlorothiazide 15/25 mg tablets (manufactured and distributed by TEVA
Pharmaceuticals USA) with that of UNIRETIC® 15/25 mg tablets (Schwartz Pharma) in healthy,
adult non-smoking subjects under fasting conditions.
Serving leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
